Clinical trial
CIPAMI-Study: Clopidogrel Administered Prehospital to Improve Primary PCI in…
NCT00372216 · Stiftung Institut fuer Herzinfarktforschung, Other · Completed
Key facts
| NCT number | NCT00372216 |
|---|---|
| Title | CIPAMI-Study: Clopidogrel Administered Prehospital to Improve Primary PCI in Patients With Acute Myocardial Infarction |
| Official title | CIPAMI-Study: Clopidogrel Administered Prehospital to Improve Primary PCI in Patients With Acute Myocardial Infarction |
| Lead sponsor | Stiftung Institut fuer Herzinfarktforschung, Other |
| Collaborators | Bristol-Myers Squibb Industry Sanofi |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Myocardial Infarction |
| Intervention type | Drug |
| Interventions | Clopidogrel (Iscover/Plavix) |
| Enrollment | 337 |
| Start date | Oct 1, 2006 |
| Primary completion | Oct 1, 2009 |
| Completion | Jan 1, 2010 |
| First posted | Sep 6, 2006 |
| Last update posted | Nov 19, 2010 |
| Countries | Austria, Germany |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: